ALPAU — Alpha Healthcare Acquisition III Income Statement
0.000.00%
Last trade - 00:00- $192.75m
- $192.73m
- 51
- 43
- 31
- 35
Annual income statement for Alpha Healthcare Acquisition III, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | |
|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | 10-K | 10-K |
| Standards: | — | USG | USG |
| Status: | Final | Final | Final |
| Total Revenue | 0 | 0 | 0 |
| Selling / General / Administrative Expenses | |||
| Total Operating Expenses | — | 0.467 | 1.65 |
| Operating Profit | 0 | -0.467 | -1.65 |
| Total Net Non Operating Interest Income / Expense | |||
| Other Net Non Operating Costs | |||
| Net Income Before Taxes | — | -0.329 | 0.596 |
| Provision for Income Taxes | |||
| Net Income After Taxes | — | -0.329 | 0.205 |
| Net Income Before Extraordinary Items | |||
| Net Income | — | -0.329 | 0.205 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||
| Income Available to Common Shareholders Including Extraordinary Items | |||
| Dilution Adjustment | |||
| Diluted Net Income | 0 | -0.329 | 0.205 |
| Diluted Weighted Average Shares | |||
| Basic EPS Including Extraordinary Items | |||
| Diluted EPS Including Extraordinary Items | |||
| Diluted EPS Excluding Extraordinary Items | |||
| Normalised Income Before Taxes | |||
| Normalised Income After Taxes | |||
| Normalised Income Available to Common Shareholders | |||
| Diluted Normalised EPS | — | -0.03 | 0.01 |